Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Natreon Awarded Patent for Indolealkylamino-withasteroid Conjugates from Sensoril - Nutraceuticals World

What are you searching for?

Sign in
Regulations

Natreon Awarded Patent for Indolealkylamino-withasteroid Conjugates from Sensoril

By: Lisa Olivo

, Rodman Media

Natreon, Inc., New Brunswick, NJ, has received a new patent for the isolation, purification and synthesis of Indolealkylamino-withasteroid conjugates from Sensoril (Withania somnifera) with potential benefits for Alzheimer’s Disease.
 
Natreon’s Sensoril (Withania somnifera), also known as Ashwagandha in Ayurveda, is a potent adaptogen used to promote health and longevity by augmenting the body’s defense mechanisms against disease, arresting the aging process, revitalizing the body in debilitated conditions, and creating a sense of well-being, the company said.  Several earlier human clinical studies have shown that Sensoril is very effective in decreasing stress levels and improving cognition. This latest patent describes a group of indolealkylamino-withasteroid conjugates isolated from Withania somnifera and purified for possible treatment of dementia and dementia-related disorders, such as Alzheimer’s Disease, anxiety, and depressive disorders in a patient.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics